As is becoming a more common event, this week’s news posting is being composed from an airport hotel room. My NJ ASTD colleagues are networking at the Annual Technology Training Showcase in Bridgewater; I’m in Chicago watching UConn stomp Gardner-Webb in basketball – oh, well.
It’s been another noisy week in pharma, mainly with the blacker black box for Avandia (see links below).
Why restrict rough product news to one Top 5 company? Sanofi‘s Acomplia gets another cloud perched over it.
Reorganization is in the air, at least in New Brunswick. Changes at J&J.
Good news Bad news for Roche. Good news – anemia drug approved by FDA! Bad news – can’t sell it…
I’m sorry. Really. Here’s a $135 million apology.
Samples for sale! Go directly to…
Forteo goes one up on Fosamax.
Door locked in Pittsburgh. Another Med. Ctr. restricts drug reps.
Not necessarily news, but a nice resource I just came across. Selling Power’s Pharmaceutical Newsletter (free registration).